Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
diagnostics
Biotech
FDA rejects another ultrarare disease prospect
The biotech’s investigational product is designed to treat an extraordinarily rare genetic metabolic disorder that impacts fewer than 1,000 Americans.
Gabrielle Masson
Sep 8, 2025 10:59am
UPDATE: Cue Health shuts down operations, lays off staff
May 22, 2024 2:15pm
Butterfly Network expands Africa maternal ultrasound efforts
Apr 15, 2024 10:58am
The road ahead as FDA tries to tame lab-developed tests
Oct 10, 2023 10:00am
CRO Cirion acquired by French diagnostic group Cerba HealthCare
Sep 14, 2023 5:30am
Bayer, Huma build online prediction tool for heart disease
Feb 6, 2023 9:53am